Evexia Lifecare has informed that Board of Directors of the Company in their Board Meeting held today , April 24, 2024 at the Registered office of the company approved the acquisition/purchase of 80% stake in Revin Labs, for consideration of Rs. 44.80 crores. Currently, the Issued and Paid up capital of the Company is Rs. 4,00,00,000 divided into 40,00,000 equity shares of Rs. 10 each. Hence, the Company will be acquiring 32,00,000 equity shares of Rs. 10 each at the issue price of Rs. 140 each (including premium amount of Rs. 130/- per share).
The above information is a part of company’s filings submitted to BSE.